Abstract
Background
Hepatitis B & C is one of the most common infectious diseases in the world and a major public health problem. It has been estimated that 350 million people worldwide are chronic hepatitis B carriers 1 . Hepatitis B virus (HBV) is rapidly spreading in developing countries including Bangladesh. In Indian subcontinent 2-5% general population is chronically infected by hepatitis B virus 2 but prevalence of HBsAg positive cases in Bangladesh is 5.5%
3 . Among them prevalence of HBV reported-a value of 8% in intravenous drug users 4 , 9.7% in commercial sex workers 5 and 5.9% in truck drivers 6 . Hepatitis B is still the most clinically significant transfusion transmissible infection with a per unit risk 1: 82000 7 and it is 50 to 100 times more infectious than HIV and important occupational hazard for health workers 8 .
Hepatitis C has approximately 175 million Global Disease Burden which represent almost 3% of the whole population in the world; each year 3 to 4 million new patients with HCV are diagnosed. The prevalence of hepatitis C in Bangladesh is about 1-3% and in professional blood donors is 2.5 % 9 . Many patients remain asymptomatic for years and are only detected on health screening or at the time of blood transfusion 10 . A study among 1018 individuals of different age groups and sex with varied religious, educational and social backgrounds in Bangladesh were tested for anti-HCV by ELISA where 0.88% tested positive for anti HCV 11 .
The prevalence of transfusion-transmitted infection in voluntary blood donors is generally much lower than among family/replacement 12, 13, 14 and paid donors 15, 16, 17 . Each country may establish voluntary blood donor programmes which provide donor information and education and develop strict national criteria for blood donor selection and deferral to exclude prospective donors at the risk of transfusion-transmitted infections 18 .
Objectives:
General:
• To determine the prevalence of asymptomatic hepatitis B and C virus in apparently healthy blood donors at in the Rajshahi Medical College Hospital.
Specific:
1. To determine the relation between the prevalence of hepatitis B and C and the sociodemographic variables.
2.
To observe the level of ALT of asymptomatic hepatitis B and C positive cases.
Materials and Methods:
The study was a cross-sectional hospital based observational study. Occupational distribution of the study respondents, 69(34.5%) patients were student, 65(32.5%) patients were service, 42(21.0%) respondents were businessman, 15(7.5%) were day labourer and 9(4.5%) participants were housewife. Among them, maximum participants 82.5% were married and rest 17.5% were unmarried.
Among donors 10 were found seropositive for HBV giving the seroprevalence of 5.0% and 4 were HCV positive giving seroprelalence of 2%. The HBV seroprevalence in male donors was 182/8(4.4%) and in female donors was 18/2(11.1%). 4 donors were found seropositive for HCV giving a seroprevalence of 2%. HCV seroprevalence in male was 182/4(2.2%) and no female. Seroprevalence of HCV and HBV were higher in younger donors, service holders, married respondents and middle class donors. 
Discussion
This cross-sectional hospital based descriptive study was conducted among 200 healthy blood donors who attended the Department of Transfusion Medicine, Rajshahi Medical College Hospital, Rajshahi during the study period. The study was aimed to determine the prevalence of asymptomatic hepatitis B and C virus in apparently healthy blood donors.
In present study the overall prevalence of HBV in this study was 5.0%. This result was lower than that obtained by Mwambungu et al. (2015), Kew et al. (1996) and Kasolo et al. (2003) 19, 20 . In other Sub-Saharan African countries, 15% has been reported from Ghana 21 29 . We also observed a higher male gender predisposition to HBV infection that is consistent with a previous report among Namibian blood donors 24 .
In present study the overall prevalence of HCV was 4(2.0%). Seroprevalence of HCV in blood donors is reported as 6% in Africa, 1.5% in Japan, 0.6% in USA, 0.24% in Finland and 0.17% in UK 30, 31 An extremely low prevalence (0.1%) has been reported in the UK and Scandinavia, a slightly higher prevalence (0.2-1%) has been reported in other European countries, Australia and North America, and the highest prevalence has been reported from Egypt (28%). In Asia the prevalence of HCV in the blood donors has been reported 5.1% from India and 1.5% from Saudi Arabia. 31, 32 In Pakistan seroprevalence varies from 0.7% to 20%. 30, 32, 33 Exact seroprevalence of Hepatitis B and C virus throughout country could not be established due to lack of representative study at national level. We also observed the prevalence rates of hepatitis C were higher among younger age group than among older group age group. These results are in contrast with what was obtained by Fathi Abed Al-Gani 34 in Jordan, Detailed epidemiological studies would be needed to further document the prevalence of seroreactivity of Hepatitis B and C in the general population and also to test the hypothesis that have been suggested in the present study. These will help in designing studies for elucidating the natural history, including modes of transmission of HBV and HCV other than parenteral transmission in our population. Larger population vaccinated for Hepatitis B may further lower the prevalence of Hepatitis B. It is important to undertake measures to keep the prevalence of viral hepatitis at low levels.
Conclusion
It is concluded from the study that seroprevalence of Hepatitis B is higher in donors than in Hepatitis C infection. Prevention is the most important aspect on which we all need to work hard. Blood is one of the main sources of transmission of Hepatitis B and C, hence donor selection is of paramount importance. With vigilant donor's selection and use of sterilized syringes and medical instruments, spread of Hepatitis B and C could be minimised.
